Vancomycin - ImmuPharma
Alternative Names: BioCIN; IPP 203101Latest Information Update: 29 Nov 2022
At a glance
- Originator ImmuPharma
- Class Antibacterials; Glycopeptides; Peptide antibiotics; Peptides
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 29 Nov 2022 Preclinical trials in Bacterial infections in United Kingdom (ImmuPharma pipeline, November 2022)